A symposium on The Next Generation of Medical Diagnostics: Applications of Nanotechnology will be held on March 4, 2008. Plenary speaker is David Baltimore, Nobel Laureate and Robert Andrews Millikan Professor of Biology.
10:00 A.M. - 6:30 P.M.
Millikan Boardroom, California Institute of Technology
Advances in nanotechnology have the potential to revolutionize medical diagnosis and therapy. Nanotechnology-based platforms for the high-throughput, multiplexed detection of proteins and nucleic acids promise to bring substantial advances in molecular medicine. Such platforms will greatly enhance the speed, accuracy, capabilities and cost-effectiveness of in vitro diagnostic testing, providing real time results for early detection without invasive testing.
This Symposium will present cutting edge medical diagnostic research advances from Caltech labs; provide insights into future medical devices from an industry perspective; and share a new vision for patient care.
Attendance at this Symposium is by invitation only. If you would like to be added to the invitation list, please contact Mary Sikora (626 395 3914). Lunch will be served at the midday break.
Registration is now closed.
Speakers Include:
From Caltech
- David Baltimore, Millikan Professor of Biology; Nobel Laureate
The New Age of Nanoscale Diagnostics - Michael Roukes, Professor of Physics, Applied Physics, and Bioengineering; Co-Founder/Director, Alliance for Nanosystems VLSI
Next-Generation Biological Large-Scale-Integration - Nate Lewis, George L. Argyros Professor and Professor of Chemistry
Breath-Based Diagnostic Detection of Lung Cancer - Changhuei Yang, Assistant Professor of Electrical Engineering and Bioengineering
Optofluidic Microscopy: A Method for Building Microscopic Microscopes - Scott Fraser, Anna L. Rosen Professor of Biology; Director, Caltech Biological Imaging Center
Building Sensors with Single-Molecule Sensitivity - Axel Sherer, Bernard A. Neches Professor of Electrical Engineering, Applied Physics, and Physics; Director, Kavli Nanoscience Institute, Caltech
Integrated Microfluidic Diagnostic Systems - Jim Heath, Elizabeth W. Gilloon Professor and Professor of Chemistry; Director, NanoSystems Biology Cancer Center
Technologies for Making In Vitro Diagnostics Cheap
From USC
- Richard J. Cote, M.D., Professor of Pathology and Urology; Director, Biomedical Nanosciences Initiative; USC School of Medicine, Norris Comprehensive Cancer Center
Patient Treatment: The Future of Diagnostic Tools
From Industry
- Joseph M. Beechem, Ph.D., Vice President, Corporate Research Lab & CTO, Invitrogen Corp
Single-Molecule, Quantum-Dot-Nanocrystal-Based Medical Diagnostics: Impact on the Future of Medicine - Frank Narz, Ph.D., Senior Scientist, QIAGEN
- Andre Ruzycky, Ph.D., Vice President, Technology Assessment, Ortho-Clinical Diagnostics, A Johnson & Johnson Company
- Christopher Amies, Ph.D., Sr. Vice President for Advanced Clinical Innovation, Siemens
- Craig Adams, Ph.D, Director, Molecular Markers